Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | Management of older adults with mantle-cell lymphoma

Jonathon Cohen • 8 Sep 2020
SOHO 2020
Lymphoma Mantle Cell Lymphoma Bendamustine Obinutuzumab Venetoclax

Jonathon B. Cohen, MD, MS, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the management of older adults with mantle-cell lymphoma, including patients with co-morbidities who may be more suitable to chemotherapy-free regimens. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Jonathon Cohen

0:57
Immunotherapeutic approaches for MCL patients who progress following BTKi treatment
Jonathon Cohen • 11 Dec 2023
0:49
Outcomes of patients with MCL who require urgent treatment at time of diagnosis
Jonathon Cohen • 11 Dec 2023
0:55
A pooled analysis to determine the optimal Ki-67 index cut-off point for predicting outcomes in MCL
Jonathon Cohen • 11 Dec 2023
0:55
Updated results of the BRUIN trial: pirtobrutinib in R/R MCL
Jonathon Cohen • 11 Dec 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals